Regeneron Pipeline Progresses On Several Fronts Despite COVID-19 Focus

 
• By Jessica Merrill

Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.

sunset golden crude pipelines in africa
Regeneron updated investors on its pipeline • Source: Shutterstock

More from Earnings

More from Business